Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome
- PMID: 23042258
- DOI: 10.1097/FTD.0b013e31826d07ea
Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome
Abstract
Background: The selective serotonin reuptake inhibitors are prescribed increasingly also during pregnancy. Although a number of studies have assessed their safety, data concerning congenital malformations and adverse perinatal outcome are conflicting.
Methods: Literature search in PubMed until March 31, 2012, including original research articles, meta-analyses, and reviews.
Results: Fluoxetine and paroxetine use in early pregnancy has been associated with a small increased risk for specific cardiovascular malformations in some studies, fluoxetine with ventricular septal defects and paroxetine with right ventricular outflow tract defects. The observed absolute risk for these specific malformations is small. Data on preterm birth, low birth weight, and being small for gestational age have been conflicting; and mother's underlying depression is obviously an important confounder. Respiratory distress and neonatal adaptation problems are common in prenatally exposed infants, and an increased risk for persistent pulmonary hypertension of the newborn has been observed in several studies. Although several studies have not confirmed an increased risk for adverse neurodevelopment, a recent study observed an increased risk for autism spectrum disorders in prenatally exposed offspring.
Conclusions: Causality cannot be confirmed in observational study settings. However, parallel results in individual studies regarding the cardiac malformations and pulmonary hypertension of the newborn, together with an existing biologically plausible mechanism behind these events may support causality. Considering the important role of serotonin in central nervous system development, more studies are needed to assess the possible adverse effects on long-term neurodevelopment.
Similar articles
-
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Encephale. 2010. PMID: 20513456 Review. French.
-
Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.Am J Obstet Gynecol. 2019 Jan;220(1):57.e1-57.e13. doi: 10.1016/j.ajog.2018.08.030. Epub 2018 Aug 28. Am J Obstet Gynecol. 2019. PMID: 30170040
-
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.J Clin Psychiatry. 2009 Mar;70(3):414-22. doi: 10.4088/jcp.08r04468. Epub 2009 Feb 24. J Clin Psychiatry. 2009. PMID: 19254517 Review.
-
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.Am J Psychiatry. 2012 Nov;169(11):1165-74. doi: 10.1176/appi.ajp.2012.11111721. Am J Psychiatry. 2012. PMID: 23128923
-
SSRI antidepressants and birth defects.Prescrire Int. 2006 Dec;15(86):222-3. Prescrire Int. 2006. PMID: 17167929
Cited by
-
Poor Neonatal Adaptation After Antidepressant Exposure During the Third Trimester in a Geographically Defined Cohort.Mayo Clin Proc Innov Qual Outcomes. 2023 Mar 7;7(2):127-139. doi: 10.1016/j.mayocpiqo.2023.02.002. eCollection 2023 Apr. Mayo Clin Proc Innov Qual Outcomes. 2023. PMID: 36938114 Free PMC article.
-
Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study.Orphanet J Rare Dis. 2017 Jun 20;12(1):116. doi: 10.1186/s13023-017-0667-4. Orphanet J Rare Dis. 2017. PMID: 28633635 Free PMC article.
-
Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram.Physiol Behav. 2017 Apr 1;172:24-30. doi: 10.1016/j.physbeh.2016.07.009. Epub 2016 Jul 13. Physiol Behav. 2017. PMID: 27422674 Free PMC article.
-
Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats.Neuropharmacology. 2015 Oct;97:251-8. doi: 10.1016/j.neuropharm.2015.05.012. Epub 2015 May 30. Neuropharmacology. 2015. PMID: 26032436 Free PMC article.
-
Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.World J Stem Cells. 2019 Feb 26;11(2):55-72. doi: 10.4252/wjsc.v11.i2.55. World J Stem Cells. 2019. PMID: 30842805 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical